-
1
Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis
Published 2023-09-01“…Cardio-Oncology…”
Get full text
Article -
2
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Published 2020-05-01“…Cardio-Oncology…”
Get full text
Article -
3
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression
Published 2023-03-01“…Cardio-Oncology…”
Get full text
Article -
4
Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study
Published 2024-04-01“…Cardio-Oncology…”
Get full text
Article -
5
Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience
Published 2021-11-01“…Cardio-Oncology…”
Get full text
Article -
6
An international survey of healthcare providers’ knowledge of cardiac complications of cancer treatments
Published 2019-09-01“…Cardio-Oncology…”
Get full text
Article -
7
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study
Published 2024-02-01“…Cardio-Oncology…”
Get full text
Article -
8
Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report
Published 2023-10-01“…Cardio-Oncology…”
Get full text
Article -
9
Echocardiographic strategy for early detection of cardiotoxicity of doxorubicin: a prospective observational study
Published 2022-10-01“…Cardio-Oncology…”
Get full text
Article -
10
14,15-Dihydroxyeicosatrienoic acid, a soluble epoxide hydrolase metabolite in blood, is a predictor of anthracycline-induced cardiotoxicity – a hypothesis generating study
Published 2023-12-01“…Cardio-Oncology…”
Get full text
Article -
11
Comprehensive molecular characterization of hypertension-related genes in cancer
Published 2022-05-01“…Cardio-Oncology…”
Get full text
Article -
12
Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapy
Published 2023-05-01“…Cardio-Oncology…”
Get full text
Article -
13
5-FU induced cardiotoxicity: case series and review of the literature
Published 2019-09-01“…Cardio-Oncology…”
Get full text
Article -
14
A case report: high dose melphalan as a conditioning regimen for multiple myeloma induces sinus arrest
Published 2020-03-01“…Cardio-Oncology…”
Get full text
Article -
15
Risk of malignancy long after acute coronary syndrome in selected urban and rural areas and comparison with smoking risk: the ABC-7* study on Heart Disease
Published 2021-02-01“…Cardio-Oncology…”
Get full text
Article -
16
Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment
Published 2017-10-01“…Cardio-Oncology…”
Get full text
Article -
17
Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Coho...
Published 2022-03-01“…Cardio-Oncology…”
Get full text
Article -
18
Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
Published 2020-10-01“…Cardio-Oncology…”
Get full text
Article -
19
The hypertensive effect of sorafenib is abolished by sildenafil
Published 2020-07-01“…Cardio-Oncology…”
Get full text
Article -
20
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Published 2017-06-01“…Cardio-Oncology…”
Get full text
Article